Our CEO Sam Windsor spoke to Oscar Vallejo from Beyond the Clinic Podcast
"We’re joined by Sam Windsor, CEO and Co-Founder of Ignota Labs - a company tackling one of the biggest hidden inefficiencies in drug development: the lack of insight into why drugs fail.
Ignota Labs rescues promising but failing drugs, bringing new life to abandoned projects and new hope to patients.
The company works with R&D teams to revisit failed assets using machine learning and biological context to suggest new hypotheses for why those drugs failed and how they could be rescued or repositioned, reviving the assets and most importantly getting them into the hands of patients.
Earlier this year, Ignota Labs raised a $6.9 million seed round, and in this episode Sam shares what they’re building, how they collaborate with partners, and why now is the time for a company like this to exist."
Listen to the episode in full: ‘Giving Drugs a Second Chance with AI, with Ignota Labs CEO and Co-Founder, Sam Windsor | EP27.’
Hosted by: Oscar Vallejo
Released: 14 May 2025 by Beyond the Clinic: Innovation in Healthcare
